Acceptability of the live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) among young women at high risk of HIV acquisition in South Africa: data from the phase 2 placebo-controlled trial

Authors

Christine Mitchell (ORCID: https://orcid.org/0000-0002-8211-281X)
Craig R. Cohen (ORCID: https://orcid.org/0000-0001-8654-6634)
Anke Hemmerling (ORCID: https://orcid.org/0000-0002-6472-4804)
Il Keun Kwon (ORCID: https://orcid.org/0000-0001-9649-3003)
Aruna Bhoola (ORCID: https://orcid.org/0000-0003-3202-8625)
Thumbi Ndung’u (ORCID: https://orcid.org/0000-0003-2962-3992)
J. Moodley
Veloshnee Govender (ORCID: https://orcid.org/0000-0002-5467-7477)
Krista L. Dong (ORCID: https://orcid.org/0000-0002-2038-3518)
Mei Dong (ORCID: https://orcid.org/0000-0002-2944-6853)
S. Pillay (ORCID: https://orcid.org/0009-0002-6355-2921)
G Casillas
Laurel A. Lagenaur

Institutions

Harvard University (US)
University of California, San Francisco (US)
Ragon Institute of MGH, MIT and Harvard (US)
Massachusetts General Hospital (US)
Aurum Institute (ZA)
Africa Health Research Institute (ZA)
Osel (United States) (US)
University College London (GB)
University of KwaZulu-Natal (ZA)

Publication Details

Journal: Frontiers in Reproductive Health
Published: 2025-03-25
DOI: https://doi.org/10.3389/frph.2025.1544458
Citations: 1
Primary Topic: Reproductive tract infections research
Type: article
Field-Weighted Citation Impact: 1.18

Funders

Bill and Melinda Gates Foundation
National Institute of Child Health and Human Development

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Acceptability of the live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) among young women at high risk of HIV acquisition in South Africa: data from the phase 2 placebo-controlled trial

Christine Mitchell, Craig R. Cohen, Anke Hemmerling, Il Keun Kwon et al.

Mar 25, 2025

1 citations

Frontiers in Reproductive Health

Reproductive tract infections research

1.18

article

Acceptability of the live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) among young women at high risk of HIV acquisition in South Africa: data from the phase 2 placebo-controlled trial

Christine Mitchell, Craig R. Cohen, Anke Hemmerling, Il Keun Kwon, Aruna Bhoola, Thumbi Ndung’u, J. Moodley, Veloshnee Govender, Krista L. Dong, Mei Dong, S. Pillay, G Casillas, Laurel A. Lagenaur

March 25, 2025article en

1 citations

Abstract

No abstract available for this paper.

Frontiers in Reproductive HealthVol. 7

Harvard University (US), University of California, San Francisco (US), Ragon Institute of MGH, MIT and Harvard (US), Massachusetts General Hospital (US), Aurum Institute (ZA), Africa Health Research Institute (ZA), Osel (United States) (US), University College London (GB), University of KwaZulu-Natal (ZA)

Bill and Melinda Gates Foundation, National Institute of Child Health and Human Development

Good health and well-being

Openalex Percentile: Top 23%

Reproductive tract infections research

1.18

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.